HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Bironzo Selected Research

Pharmaceutical Preparations

1/2022Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response.
5/2021Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma.
12/2020Resistance to anaplastic lymphoma kinase inhibitors: knowing the enemy is half the battle won.
1/2020New emerging targets in cancer immunotherapy: the role of VISTA.
2/2016Raising the bar for enthusiasm when looking at results of randomized phase II trials-the case of sunitinib in small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Bironzo Research Topics

Disease

21Neoplasms (Cancer)
08/2022 - 04/2012
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 04/2012
9Lung Neoplasms (Lung Cancer)
01/2022 - 05/2018
7Malignant Mesothelioma
04/2022 - 11/2018
4Mesothelioma
08/2022 - 11/2018
3Adenocarcinoma of Lung
12/2022 - 01/2021
3Disease Progression
05/2021 - 02/2016
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 12/2013
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2021 - 02/2016
2Sarcoma (Soft Tissue Sarcoma)
01/2021 - 12/2014
2Pleurisy (Pleuritis)
01/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2021 - 11/2020
2Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 01/2017
1COVID-19
01/2022
1Lung Diseases (Lung Disease)
08/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Solitary Fibrous Tumors
01/2021
1Synovial Sarcoma (Synovioma)
01/2021
1Fasciitis (Fascitis)
01/2021
1Fibroma (Fibromatosis)
01/2021
1Hemangiosarcoma (Angiosarcoma)
01/2021
1Aggressive Fibromatosis (Desmoid)
01/2021
1Hyperplasia
01/2021
1Leiomyosarcoma
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Circulating Neoplastic Cells
12/2020
1Infections
01/2020
1Pulmonary Arterial Hypertension
01/2019
1Hypoxia (Hypoxemia)
05/2018
1Nausea
04/2018
1Vomiting
04/2018
1Leukemia
02/2016

Drug/Important Bio-Agent (IBA)

13Immune Checkpoint InhibitorsIBA
12/2022 - 09/2017
5Pharmaceutical PreparationsIBA
01/2022 - 02/2016
4Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2017
3Pemetrexed (MTA)FDA Link
08/2022 - 11/2018
3Thymidylate SynthaseIBA
08/2022 - 01/2021
3ErbB Receptors (EGF Receptor)IBA
05/2022 - 07/2012
3Cisplatin (Platino)FDA LinkGeneric
02/2022 - 04/2012
3AsbestosIBA
05/2021 - 11/2018
3Tyrosine Kinase InhibitorsIBA
05/2021 - 12/2014
3pembrolizumabIBA
01/2021 - 09/2019
3abirateroneIBA
01/2018 - 12/2013
2Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2022
2Biological ProductsIBA
01/2022 - 09/2021
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2021 - 01/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
09/2021 - 01/2021
2PlatinumIBA
05/2021 - 04/2012
2B7-H1 AntigenIBA
01/2021 - 11/2020
2Carboplatin (JM8)FDA LinkGeneric
04/2018 - 02/2016
2AndrogensIBA
01/2018 - 12/2013
2enzalutamideIBA
01/2018 - 12/2015
2Hormones (Hormone)IBA
01/2018 - 12/2013
2DNA (Deoxyribonucleic Acid)IBA
03/2015 - 04/2012
1MicroRNAs (MicroRNA)IBA
08/2022
1Thioredoxin-Disulfide ReductaseIBA
05/2022
1Codon (Codons)IBA
05/2022
1defactinibIBA
05/2022
1pevonedistatIBA
02/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1PM 01183IBA
05/2021
1niraparibIBA
01/2021
1durvalumabIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
11-methyl-1-piperidinomethane sulfonateIBA
01/2021
1dostarlimabIBA
01/2021
1InterferonsIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
12/2020
1Circulating Tumor DNAIBA
12/2020
1CD4 Antigens (CD4 Antigen)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1MucinsIBA
01/2019
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
01/2019
1Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1MIA-690IBA
01/2019
1Peptides (Polypeptides)IBA
12/2018
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2018
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2018
1CytokinesIBA
05/2018
1Thymidine PhosphorylaseIBA
05/2018
1pyrimidineIBA
05/2018
1Leucovorin (Folinic Acid)FDA Link
05/2018
1EnzymesIBA
05/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2018
1Neurokinin-1 Receptor AntagonistsIBA
04/2018
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
04/2018
1Abiraterone AcetateIBA
01/2018
1Androgen Antagonists (Antiandrogens)IBA
01/2018
1Etoposide (VP 16)FDA LinkGeneric
02/2016
1Sunitinib (Sutent)FDA Link
02/2016

Therapy/Procedure

11Drug Therapy (Chemotherapy)
08/2022 - 04/2012
10Therapeutics
02/2022 - 07/2012
8Immunotherapy
12/2022 - 12/2018
2Castration
01/2018 - 12/2015
1Nutritional Support (Artificial Feeding)
01/2022
1Combination Drug Therapy (Combination Chemotherapy)
08/2019